Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril.

@article{Textor1982HyperkalemiaIA,
  title={Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril.},
  author={Stephen C. Textor and Emmanuel L Bravo and Fetnat M. Fouad and Robert C. Tarazi},
  journal={The American journal of medicine},
  year={1982},
  volume={73 5},
  pages={719-25}
}
Thirty-three hypertensive patients with a wide range of renal function were studied during initiation of angiotensin-converting enzyme inhibition with captopril to evaluate changes in potassium levels concomitant with reduction of aldosterone excretion. Ten patients (Group I) with low levels of plasma renin activity had no change in either aldosterone excretion or potassium during the first week of therapy. Twenty-three other patients (Group II) had decreased aldosterone excretion of an average… CONTINUE READING